The effect of laser and cream 5 fluorouracil 5% in treatment of vitiligo
Not Applicable
- Conditions
- vitiligo.vitiligo
- Registration Number
- IRCT2016090229647N1
- Lead Sponsor
- Deputy of research of Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
Inclusion/exclusion criteria:
Age =15 years; patient suffering from vitiligo with at least 2 patch on limbs or trunk( except periungual areas and genitalia); no follicular pigmentation and depigmented hair on lesion
Exclusion Criteria
Incidence of drug adverse effects; patients with poor compliance for visit and follow up; pregnancy and lactation; patients with hepatic or hematologic or renal disease; simultaneous application of other therapies .
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vitiligo lesion size change and pigmentation score. Timepoint: 2 months and then 4 months after treatment start. Method of measurement: by pictzar software and pigmentation score for vitiligo by an independent dermatologists blinded to the randomization.
- Secondary Outcome Measures
Name Time Method Pain,burning,Pruritis;atrophy,telangiectasia,acne,scar,swelling, tenderness, infection. Timepoint: Two days, one week , two months and four months after treatment start. Method of measurement: Visit, history and physical examination.